The Effect of Bright Light Treatment on Rest-Activity Rhythms in People with Dementia: A 24-Week Cluster Randomized Controlled Trial

被引:5
|
作者
Kolberg, Eirin [1 ]
Pallesen, Stale [2 ,3 ,4 ]
Hjetland, Gunnhild Johnsen [1 ,5 ]
Nordhus, Inger Hilde [1 ,6 ]
Flo-Groeneboom, Elisabeth [1 ]
机构
[1] Univ Bergen UiB, Fac Psychol, Dept Clin Psychol, N-5009 Bergen, Norway
[2] Univ Bergen UiB, Fac Psychol, Dept Psychosocial Sci, N-5015 Bergen, Norway
[3] Haukeland Hosp, Norwegian Competence Ctr Sleep Disorders, N-5021 Bergen, Norway
[4] North West Univ, Optentia, Vaal Triangle Campus, ZA-1911 Vanderbijlpark, South Africa
[5] City Dept Hlth & Care, N-5007 Bergen, Norway
[6] Univ Oslo UiO, Fac Med, Dept Behav Med, N-0372 Oslo, Norway
来源
CLOCKS & SLEEP | 2021年 / 3卷 / 03期
关键词
dementia; nursing homes; bright light therapy; rest-activity rhythms; actigraphy; circadian rhythms; clinical trial; CIRCADIAN ACTIVITY RHYTHMS; NURSING-HOME RESIDENTS; MINI-MENTAL-STATE; ALZHEIMERS-DISEASE; INSTITUTIONALIZED PATIENTS; MELATONIN SECRETION; SLEEP; EXPOSURE; DISTURBANCES; INTERVENTION;
D O I
10.3390/clockssleep3030032
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Bright light treatment is an effective way to influence circadian rhythms in healthy adults, but previous research with dementia patients has yielded mixed results. The present study presents a primary outcome of the DEM.LIGHT trial, a 24-week randomized controlled trial conducted at nursing homes in Bergen, Norway, investigating the effects of a bright light intervention. The intervention consisted of ceiling-mounted LED panels providing varying illuminance and correlated color temperature throughout the day, with a peak of 1000 lx, 6000 K between 10 a.m. and 3 p.m. Activity was recorded using actigraphs at baseline and after 8, 16, and 24 weeks. Non-parametric indicators and extended cosine models were used to investigate rest-activity rhythms, and outcomes were analyzed with multi-level regression models. Sixty-one patients with severe dementia (median MMSE = 4) were included. After 16 weeks, the acrophase was advanced from baseline in the intervention group compared to the control group (B = -1.02, 95%; CI = -2.00, -0.05). There was no significant difference between the groups on any other rest-activity measures. When comparing parametric and non-parametric indicators of rest-activity rhythms, 25 out of 35 comparisons were significantly correlated. The present results indicate that ambient bright light treatment did not improve rest-activity rhythms for people with dementia.
引用
收藏
页码:449 / 464
页数:16
相关论文
共 50 条
  • [41] Providing activity for people with dementia in care homes: a cluster randomised controlled trial
    Wenborn, Jennifer
    Challis, David
    Head, Jenny
    Miranda-Castillo, Claudia
    Popham, Carolyn
    Thakur, Ruchi
    Illes, Jacqueline
    Orrell, Martin
    INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY, 2013, 28 (12) : 1296 - 1304
  • [42] A 24-week randomized, double-blind, placebo-controlled study of the efficacy and tolerability of TNFR: Fc (etanercept) in the treatment of dementia of the Alzheimer type
    Bohac, D
    Burke, W
    Cotter, R
    Zheng, J
    Potter, J
    NEUROBIOLOGY OF AGING, 2002, 23 (01) : S83 - S83
  • [43] Bright Light Treatment of Combat-related PTSD: A Randomized Controlled Trial
    Youngstedt, Shawn D.
    Kline, Christopher E.
    Reynolds, Alexandria M.
    Crowley, Shannon K.
    Burch, James B.
    Khan, Nidha
    Han, SeungYong
    MILITARY MEDICINE, 2022, 187 (3-4) : E435 - E444
  • [44] The effect of a buddy-style intervention on physical activity in community-dwelling older adults with disabilities: A 24-week follow-up of a randomized controlled trial
    Takeda, Hiromichi
    Takatori, Katsuhiko
    CLINICAL REHABILITATION, 2022, 36 (12) : 1590 - 1600
  • [45] Donepezil improves cognition in patients with vascular dementia: Results from study 307, a 24-week, randomized, double-blind, placebo-controlled trial
    Roman, GC
    Pratt, RD
    Perdomo, CA
    Perdomo, CA
    NEUROBIOLOGY OF AGING, 2002, 23 (01) : S55 - S55
  • [46] Bexagliflozin as an adjunct to metformin for the treatment of type 2 diabetes in adults: A 24-week, randomized, double-blind, placebo-controlled trial
    Halvorsen, Yuan-Di
    Conery, Annie L.
    Lock, John Paul
    Zhou, Wenjiong
    Freeman, Mason W.
    DIABETES OBESITY & METABOLISM, 2023, 25 (10): : 2954 - 2962
  • [47] Effect of a 24-week weight management program on serum leptin level in correlation to anthropometric measures in obese female: A randomized controlled clinical trial
    Rashad, Nearmeen M.
    Sayed, Sally E.
    Sherif, Mohamed H.
    Sitohy, Mahmoud Z.
    DIABETES & METABOLIC SYNDROME-CLINICAL RESEARCH & REVIEWS, 2019, 13 (03) : 2230 - 2235
  • [48] Low-Level Light Therapy for Androgenetic Alopecia: A 24-Week, Randomized, Double-Blind, Sham Device-Controlled Multicenter Trial
    Kim, Hyojin
    Choi, Jee Woong
    Kim, Jun Young
    Shin, Jung Won
    Lee, Seok-jong
    Huh, Chang-Hun
    DERMATOLOGIC SURGERY, 2013, 39 (08) : 1177 - 1183
  • [49] Efficacy and safety of infliximab in patients with ankylosing spondylitis: Results of a 24-week randomized, placebo-controlled trial (ASSERT)
    van der Heijde, D
    Dijkmans, B
    Geusens, P
    Sieper, J
    DeWoody, K
    Williamson, R
    Braun, J
    ANNALS OF THE RHEUMATIC DISEASES, 2004, 63 : 403 - 403
  • [50] Orlistat 60 mg Reduces Visceral Adipose Tissue: A 24-Week Randomized, Placebo-Controlled, Multicenter Trial
    Smith, Steven R.
    Stenlof, Kaj S.
    Greenway, Frank L.
    McHutchison, John
    Schwartz, Susan M.
    Dev, Vidhu B.
    Berk, Evan S.
    Kapikian, Roxanne
    OBESITY, 2011, 19 (09) : 1796 - 1803